Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Product Liability Law & StrategyKickerFeaturesTopicsLitigationRegulationSectionsNewsLJN Newsletters

Practice Tip: Medical Expenses In CA

By Julia M. Beckley
December 31, 2013

Damages in product liability personal injury cases inevitably involve medical expenses. Depending on the nature and extent of the injury, those medical expenses can generate extraordinarily high numbers, especially when examining the amount billed without insurance discounts. When it comes to recovering medical expenses, the question in determining the amount of damages often turns on what number can be presented to the jury: Do we recover the amount billed by the medical providers? Or the out-of-pocket amount actually paid by the plaintiff? The differential between the amount billed versus paid can be substantial, and understanding the admissibility of the figures can have a large impact on the potential damages in your case.

Since the California Supreme Court's decision in Howell v. Hamilton Meats & Provisions, Inc ., (2011) 52 Cal.4th 541, California law has been clear that plaintiffs cannot recover medical damages in excess of those they have paid. The Howell court indirectly opined that evidence of the full amount of an injured plaintiff's medical billings is inadmissible with respect to damages for past medical expenses. The decision, however, left the door open for plaintiffs to seek the admissibility of the full medical billings with respect to the calculation of potential future medical expenses and noneconomic damages. The recent decision in Corenbaum v. Lampkin, (2013) 215 Cal.App.4th 1308, closed that door.

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.

Compliance Officers: Recent Regulatory Guidance and Enforcement Actions and Mitigating the Risk of Personal Liability Image

This article explores legal developments over the past year that may impact compliance officer personal liability.